Latest news with #KfinTechnologies
Time of India
15 hours ago
- Business
- Time of India
JSW Cement IPO allotment to be finalised today. Check status, GMP and other details
JSW Cement will finalise the basis of allotment for its Rs 3,600 crore IPO, with investors able to check whether they have secured shares in the issue. The IPO, which ran from August 7 to August 11, 2025, saw a healthy overall subscription of 7.7 times, led by robust demand from institutional investors. The qualified institutional buyers (QIB) category was subscribed 15.8 times, non-institutional investors (NII) 10.97 times, while the retail portion managed 1.81 times subscription. In the grey market, JSW Cement shares are quoting at a modest premium of around 4% over the issue price, signalling cautious optimism ahead of listing. How to check allotment status Applicants can verify their allotment status through the registrar, Kfin Technologies . Visit the Kfintech IPO allotment status page ( ). Select 'JSW Cement' from the dropdown list. Enter your PAN number, application number, or DP/Client ID. Click 'Search' to view your allotment details. Investors can also check their IPO allotment status through the BSE website Go to Select 'Equity' and 'JSW Cement' from the dropdowns. Enter your application number and PAN. Click 'Search' to check your status. Refunds for unallotted applications and credit of shares to successful investors' demat accounts are expected on August 13. The stock is scheduled to list on both the BSE and NSE on August 14. JSW Cement, part of the JSW Group, is a major manufacturer of green cement, operating seven plants across India with an installed grinding capacity of 20.6 million tonnes per annum. The IPO comprised a fresh issue of 10.88 crore shares worth Rs 1,600 crore and an offer for sale of 13.61 crore shares worth Rs 2,000 crore by the promoters. The price band was set at Rs 139–147 per share, with a lot size of 102 shares. Proceeds from the fresh issue will be used to part-finance a new integrated cement unit at Nagaur, Rajasthan, prepay or repay certain borrowings, and for general corporate purposes. Given the company's recent financial performance — including a loss in FY25 after two profitable years — market watchers believe listing-day moves could depend heavily on broader market sentiment and investor outlook on the cement sector. ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
News18
04-08-2025
- Business
- News18
Sri Lotus Developers IPO Allotment Today: A Step-By-Step Guide To Check Status Online, Know Latest GMP
Last Updated: Sri Lotus Developers IPO GMP: Its grey market premium currently stands at 24.67%, indicating strong listing gains for investors. Sri Lotus Developers IPO Allotment Status and Latest GMP: The basis of allotment of the Sri Lotus Developers IPO is expected to be finalised today, August 4, in the evening. Once finalised, investors can check their allotment status on the websites of registrar Kfin Technologies as well as exchanges BSE and NSE. They will also receive a bank debit/ unblock SMS. The IPO was open between July 30 and August 1. On the final day of bidding on Friday, the issue received a 74.10 times subscription, garnering bids for 2,74,25,55,800 shares as against the 3,70,13,726 shares on offer. The retail and NII participation stood at 21.77x and 61.82x, respectively. The QIB category has received a 175.61x subscription. Choose an Identification Mode: Select one of the following options to check your status: Enter Details: Input the details corresponding to the selected mode (e.g., your PAN, application number, or Demat account details). Complete CAPTCHA: Fill in the CAPTCHA for security verification and click 'Submit' to view your allotment status. The status will show whether shares were allotted and, if so, how many. Option 2: Check Allotment Status on BSE Website You can also check the allotment status on the BSE website. Here's how: Visit the BSE IPO Page: Go to Select Issue Type: Choose 'Equity" as the issue type. Select IPO: From the dropdown menu, select 'Sri Lotus Developers Limited'. Complete CAPTCHA: Tick the 'I'm not a robot" CAPTCHA and click 'Search" to view your allotment status. Sri Lotus Developers IPO GMP Today According to market observers, unlisted shares of Sri Lotus Developers Ltd are currently trading at Rs 187 against the upper IPO price of Rs 150. It means a grey market premium or GMP of Rs 37, which is 24.67% over its issue price. The GMP is based on market sentiments and keeps changing. 'Grey market premium' indicates investors' readiness to pay more than the issue price. Sri Lotus Developers IPO More Info The price band of the mainboard IPO, which plans to raise Rs 792 crore, has been fixed at Rs 150 apiece. The IPO is entirely a fresh issue of shares worth Rs 792 crore with no Offer For Sale (OFS) component. Proceeds from the fresh issue will be used for investment in its subsidiaries, Richfeel Real Estate Pvt Ltd, Dhyan Projects Pvt Ltd and Tryksha Real Estate Pvt Ltd for part-funding the development and construction cost of its ongoing projects, Amalfi, The Arcadian and Varun, respectively; besides, a portion will be used for general corporate purposes. The Anand Kamalnayan Pandit-promoted company is a real estate developer engaged in the construction of residential and commercial premises in Mumbai, Maharashtra, with a focus on redevelopment projects in the ultra luxury and luxury segments in the western suburbs. Monarch Networth Capital and Motilal Oswal Investment Advisors are the book-running lead managers of the public issue. tags : initial public offering (IPO) IPO view comments Location : New Delhi, India, India First Published: August 04, 2025, 09:07 IST News business » ipo Sri Lotus Developers IPO Allotment Today: A Step-By-Step Guide To Check Status Online, Know Latest GMP Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
News18
18-07-2025
- Business
- News18
Anthem Biosciences IPO Allotment Finalised, Listing On Monday: What Does Latest GMP Signal?
Anthem Biosciences IPO: Investors can check their allotment status on the websites of registrar Kfin Technologies as well as exchanges BSE and NSE. Anthem Biosciences IPO Allotment Status And GMP: The basis of allotment of the Anthem Biosciences IPO has been finalised, and investors can check their allotment status on the websites of registrar Kfin Technologies as well as exchanges BSE and NSE. Now, all eyes are on its listing, which is scheduled to take place on both BSE and NSE on Monday, July 21. The IPO was open for public subscription between July 14 and July 16. It received a strong 67.42 times subscription, garnering bids for 2,81,49,30,794 shares as against the 4,17,50,321 shares on offer. The retail and NII participation stood at 5.98x and 44.70x, respectively. The QIB category received a 192.80x subscription. Option 1: Kfin Technologies (Registrar) Website Enter Details: Input the details corresponding to the selected mode (e.g., your PAN, application number, or Demat account details). Complete CAPTCHA: Fill in the CAPTCHA for security verification and click 'Submit' to view your allotment status. The status will show whether shares were allotted and, if so, how many. Option 2: Check Allotment Status on BSE Website You can also check the allotment status on the BSE website. Here's how: Visit the BSE IPO Page: Go to Select Issue Type: Choose 'Equity" as the issue type. Select IPO: From the dropdown menu, select 'Anthem Biosciences Limited'. Complete CAPTCHA: Tick the 'I'm not a robot" CAPTCHA and click 'Search" to view your allotment status. Anthem Biosciences IPO GMP Today The IPO's grey market premium currently stands at 25.26%, indicating strong listing gains. According to market observers, unlisted shares of Anthem Biosciences Ltd are currently trading at Rs 714 against its upper IPO price of Rs 570. It means a grey market premium or GMP of Rs 144, which is 25.26% over its issue price, indicating strong listing. The GMP is based on market sentiments and keeps changing. 'Grey market premium' indicates investors' readiness to pay more than the issue price. The price band of the mainboard IPO, which aims to raise Rs 3,395 crore, was fixed in the range of Rs 540 to Rs 570. The IPO is entirely an offer-for-sale (OFS). So, the company will not receive any funds from the issue and the proceeds will go to the selling shareholders. Anthem Biosciences raised Rs 1,016 crore from anchor investors ahead of its initial share-sale opening for public subscription. Some of the investors that participated in the anchor book are — Abu Dhabi Investment Authority, Government Pension Fund Global, Eastspring Investments, Amundi Funds, PineBridge Global Funds and Societe Generale, HDFC MF (MF), ICICI Prudential MF, Axis MF, UTI MF, Quant MF and Motilal Oswal MF. Anthem is into innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (CRDMO) with fully integrated operations spanning across drug discovery, development and manufacturing. It also manufactures and sells complex specialized fermentation-based Active Pharmaceutical Ingredients (APIs), including probiotics, enzymes, peptides, nutritional actives, vitamin analogues and biosimilars. Sai Life Sciences Ltd, Syngene International, Suven Life Sciences and Divi's Laboratories are the listed peers of Anthem Biosciences. JM Financial, Citigroup Global Markets India, J P Morgan India and Nomura Financial Advisory and Securities (India) are the book-running lead managers for the issue. Stay updated with all the latest business news, including market trends, stock updates, tax, IPO, banking finance, real estate, savings and investments. Get in-depth analysis, expert opinions, and real-time updates—only on News18. Also Download the News18 App to stay updated! tags : initial public offering (IPO) IPO view comments Location : New Delhi, India, India First Published: July 18, 2025, 10:45 IST News business » ipo Anthem Biosciences IPO Allotment Finalised, Listing On Monday: What Does Latest GMP Signal? Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
&w=3840&q=100)
Business Standard
11-07-2025
- Business
- Business Standard
GLEN Industries IPO allotment today; check status, latest GMP, listing date
GLEN Industries IPO allotment status: The basis of allotment of shares for GLEN Industries is expected to be finalised today, Friday, July 11, 2025. The initial public offering (IPO) of GLEN Industries, which closed its three-day subscription window on Thursday, July 10, received an overwhelming response from investors, with the offering being oversubscribed nearly 242.32 times, riding on the back of the non-institutional investors who bid for a whopping 350.72 times the quota reserved for them, showed the BSE data. Here's how to check the GLEN Industries IPO allotment status online Once the allotment of GLEN Industries IPO shares is finalised, investors can check their status on the official websites of the BSE and Kfin Technologies, the registrar for the issue. Alternatively, investors can also use the following direct links to check the GLEN Industries IPO allotment status online: GLEN Industries IPO details The SME offering, valued at around ₹63.02 crore, comprises an entirely fresh issue of 6.5 million equity shares without any offer-for-sale (OFS) component. The public issue was open for subscription from Tuesday, July 8, 2025, to Thursday, July 10, 2025. It was priced in the range of ₹92–97 per share, with a lot size of 1,200 shares. Kfin Technologies is serving as the registrar, while GYR Capital Advisors acts as the sole book-running lead manager for the IPO. GLEN Industries plans to utilise the IPO proceeds for setting up a new manufacturing facility at Purba Bardhaman, West Bengal. The company will further use the proceeds for general corporate purposes. GLEN Industries IPO grey market premium (GMP), listing estimate Shares of GLEN Industries were commanding a solid premium in the grey markets on Friday. According to sources tracking unofficial market activities, GLEN Industries shares were quoted at around ₹142 per share, reflecting a grey market premium (GMP) of ₹45 or 46.39 per cent over the upper end of the issue price. Shares of GLEN Industries are tentatively expected to list on the BSE SME platform on Tuesday, July 15, 2025. The current GMP trend suggests a solid listing for the company's shares. Should the current grey market trends sustain, GLEN Industries shares may yield a return of over 46 per cent to allotted shareholders. However, it is important to note that GMP is an unregulated market indicator and should not be relied upon for assessing the company's actual market performance. About GLEN Industries Glen Industries manufactures eco-friendly food packaging and service products, including thin-wall containers and compostable straws. The company serves sectors like Hotels, Restaurants, and Cafés, as well as the beverage industry. Glen Industries has a 90,000 sq. ft. manufacturing facility in Dhulagarh, equipped with advanced machines, and exports products to regions like Europe, the USA, and Australia. The company's product portfolio includes thin-wall food containers and compostable straws, with varying production capacities.
&w=3840&q=100)
Business Standard
09-07-2025
- Business
- Business Standard
Meta Infotech IPO booked 155x; check allotment status, GMP, listing date
Meta Infotech IPO allotment status: The initial public offering (IPO) of cybersecurity solutions company, Meta Infotech, received an overwhelming response from the investors across categories on the third and final day of subscription on July 8, 2025. According to BSE data, Meta Infotech IPO was booked 155.28 times on the last day of bidding. The issue received bids for around 555.53 million shares compared to 3.57 million equity shares on the offer. The demand was led by non-institutional investors (NIIs), who subscribed to the allotted portion by 197.52 times, followed by qualified institutional buyers (QIBs) at 147.76 times and retail investors at 122.06 times. However, the portion booked for employees was subscribed to only 59 per cent. Here's how to check Meta Infotech IPO allotment status: Investors who participated in the Meta Infotech IPO can check their allotment status on the official websites of BSE or Kfin Technologies, the issue registrar. Visit the BSE IPO allotment status page - Select 'Equity' as issue type From the dropdown menu, select "Meta Infotech" Enter your application number or PAN Complete verification Click on 'Search' and your allotment status will appear on the screen. Steps to check Meta Infotech IPO allotment status on Kfin Technologies: Go to the IPO allotment status page on the Kfin Technologies website - Choose "Meta Infotech" from the dropdown menu Enter your application number, Demat or PAN Click on submit and enter the captcha to view your allotment status Meta Infotech IPO grey market premium (GMP) The unlisted shares of Meta Infotech were trading at ₹206 in the grey market, commanding a premium of ₹45 or 27.95 per cent compared to the upper end price of ₹161, according to the sources tracking unofficial markets. Meta Infotech IPO details The SME offering opened for bidding on Friday, July 4 and closed on Tuesday, July 8, 2025. Shares of Meta Infotech are scheduled to list on the BSE SME platform on Friday, July 11, 2025. The company has set the price band in the range of ₹153 to ₹161, with a lot size of 800 shares. Hem Securities is the book-running lead manager of the issue. About Meta Infotech Incorporated in 1998, Meta Infotech provides cybersecurity solutions for various industries, including banking, IT and manufacturing. The company delivers comprehensive cybersecurity solutions and services for protecting and maintaining the integrity of information and systems. It procures the cybersecurity products from various international OEMs who develop solutions to ensure secure access, defence for web applications, cloud workload protection, etc. In addition, the company has entered into agreements as authorised resellers with various OEMs for the distribution of cybersecurity products, software along with its licenses and subscriptions etc.
